Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Profit After Tax: 2019-2024

Historic Profit After Tax for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to -$260.2 million.

  • Agilon Health's Profit After Tax rose 629.85% to -$110.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$308.3 million, marking a year-over-year increase of 1990.15%. This contributed to the annual value of -$260.2 million for FY2024, which is 100.91% up from last year.
  • As of FY2024, Agilon Health's Profit After Tax stood at -$260.2 million, which was up 100.91% from -$262.8 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Profit After Tax registered a high of -$63.2 million during FY2020, and its lowest value of -$406.8 million during FY2021.
  • For the 5-year period, Agilon Health's Profit After Tax averaged around -$220.0 million, with its median value being -$260.2 million (2024).
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 7764.45% in 2020, then plummeted by 54356.89% in 2021.
  • Annual analysis of 5 years shows Agilon Health's Profit After Tax stood at -$63.2 million in 2020, then plummeted by 543.57% to -$406.8 million in 2021, then surged by 73.73% to -$106.9 million in 2022, then tumbled by 145.92% to -$262.8 million in 2023, then rose by 1.01% to -$260.2 million in 2024.
  • Its last three reported values are -$260.2 million in FY2024, -$262.8 million for FY2023, and -$106.9 million during FY2022.